Journal
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Volume 24, Issue 7, Pages 4092-4104Publisher
WILEY
DOI: 10.1111/jcmm.15063
Keywords
bladder cancer; carcinogenesis; METTL3; YTHDF2 m(6)A axis; mRNA degradation; RNA modification
Categories
Funding
- National Natural Science Foundation of China [81972374, 81702500, 81802564, 81874203]
- Natural Science Foundation of Zhejiang Province [LY20H160022]
- National Key Research and Development Program of China [2017YFC0908002, 2017YFC0908003]
- Zhejiang Province Medical and Health Scientific Research Project [2019RC033, 2020KY542]
- China Postdoctoral Science Foundation [2018M632489]
Ask authors/readers for more resources
N6-Methyladenosine (m(6)A) modification, the most prevalent modification of eukaryotic messenger RNA (mRNA), is involved in the progression of various tumours. However, the specific role of m(6)A in bladder cancer (BCa) is still poorly understood. In this study, we demonstrated the tumour-promoting function and specific regulatory mechanism of m(6)A axis, consisting of the core 'writer' protein METTL3 and the major reader protein YTHDF2. Depletion of METTL3 impaired cancer proliferation and cancer metastasis in vitro and in vivo. Through transcriptome sequencing, m(6)A methylated RNA immunoprecipitation (MeRIP) and RIP, we determined that the METTL3/YTHDF2 m(6)A axis directly degraded the mRNAs of the tumour suppressors SETD7 and KLF4, contributing to the progression of BCa. In addition, overexpression of SETD7 and KLF4 revealed a phenotype consistent with that induced by depletion of the m(6)A axis. Thus, our findings on the METTL3/YTHDF2/SETD7/KLF4 m(6)A axis provide the insight into the underlying mechanism of carcinogenesis and highlight potential therapeutic targets for BCa.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available